Medifast [MED] vs WW International [WW] Detailed Stock Comparison

Medifast Inc.

NYSE
Loading...

WW International Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Medifast Inc. wins in 4 metrics, WW International Inc. wins in 13 metrics, with 0 ties. WW International Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medifast Inc. WW International Inc. Better
P/E Ratio (TTM) 531.50 1.23 WW International Inc.
Price-to-Book Ratio 0.57 0.29 WW International Inc.
Debt-to-Equity Ratio 5.38 147.33 Medifast Inc.
PEG Ratio -0.22 -16.02 Medifast Inc.
EV/EBITDA -1,469.18 2.70 WW International Inc.
Profit Margin (TTM) -4.84% 148.60% WW International Inc.
Operating Margin (TTM) -10.39% -5.38% WW International Inc.
Return on Equity -9.13% 332.00% WW International Inc.
Return on Assets (TTM) -3.34% 6.74% WW International Inc.
Free Cash Flow (TTM) $1.25M $-46.38M Medifast Inc.
1-Year Return -10.95% 6,292.31% WW International Inc.
Price-to-Sales Ratio (TTM) 0.32 0.13 WW International Inc.
Enterprise Value $-42.61M $401.21M WW International Inc.
EV/Revenue Ratio -0.11 0.57 WW International Inc.
Gross Profit Margin (TTM) 69.43% 70.08% WW International Inc.
Revenue per Share (TTM) $35 $16 Medifast Inc.
Earnings per Share (Diluted) $-1.70 $7.58 WW International Inc.
Beta (Stock Volatility) 0.56 N/A N/A
Short % of Float 19.31% N/A N/A

Medifast Inc. vs WW International Inc. Stock Performance Analysis

Loading Price Chart...

MED
WW

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medifast Inc.0.25%-6.69%15.43%14.57%12.98%17.98%
WW International Inc.7.04%0.94%58.20%-25.18%-33.41%-45.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medifast Inc.-10.95%-85.01%-95.99%-61.95%-51.02%-36.36%
WW International Inc.6,292.31%131.15%-58.43%9.85%-78.19%-60.76%

Performance & Financial Health Analysis: Medifast Inc. vs WW International Inc.

MetricMEDWW
Market Information
Market Cap i$121.13M$92.67M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i240,387340,575
90 Day Avg. Volume i275,592412,935
Last Close$12.27$17.26
52 Week Range$9.22 - $15.46$8.36 - $46.95
% from 52W High-20.63%-63.23%
All-Time High$336.99 (May 24, 2021)$105.73 (Jun 18, 2018)
% from All-Time High-96.36%-83.68%
Growth Metrics
Quarterly Revenue Growth-0.37%-0.12%
Quarterly Earnings Growth-0.37%-0.19%
Financial Health
Profit Margin (TTM) i-0.05%1.49%
Operating Margin (TTM) i-0.10%-0.05%
Return on Equity (TTM) i-0.09%3.32%
Debt to Equity (MRQ) i5.38147.33
Cash & Liquidity
Book Value per Share (MRQ)$19.29$31.83
Cash per Share (MRQ)$16.22$16.03
Operating Cash Flow (TTM) i$6.86M$-28,897,000
Levered Free Cash Flow (TTM) i$5.41M$23.84M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Medifast Inc. vs WW International Inc.

MetricMED (Apr 24, 2026)WW (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i531.501.23
Forward P/E i-4.00-16.02
PEG Ratio i-0.22-16.02
Price to Sales (TTM) i0.320.13
Price to Book (MRQ) i0.570.29
Market Capitalization
Market Capitalization i$121.13M$92.67M
Enterprise Value i$-42,606,284$401.21M
Enterprise Value Metrics
Enterprise to Revenue i-0.110.57
Enterprise to EBITDA i-1,469.182.70
Risk & Other Metrics
Beta i0.56N/A
Book Value per Share (MRQ) i$19.29$31.83

Financial Statements Comparison: Medifast Inc. vs WW International Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMED (2025)WW (2025)
Revenue/Sales i385.79M710.64M
Cost of Goods Sold i110.60M200.14M
COGS % of Revenue i28.7%28.2%
Gross Profit i275.19M510.50M
Gross Margin i71.3%71.8%
Research & Development iN/A42.39M
Operating Income (EBIT) i-14.21M46.43M
Operating Margin i-3.7%6.5%
EBITDA i29,000106.18M
EBITDA Margin i0.0%14.9%
Pre-Tax Income i-5.64M1.09B
Pre-Tax Income % of Revenue i-1.5%153.6%
Income Tax i13.03M35.45M
Income Tax % of Revenue i3.4%5.0%
Net Income (Profit) i-18.67M1.06B
Profit Margin i-4.8%148.6%

Balance Sheet & Liquidity Metrics

MetricMED (2025)WW (2025)
Cash & Equivalents i89.30M160.28M
Total Current Assets i201.68M213.60M
Total Current Assets % of Revenue i52.3%30.1%
Total Current Liabilities i42.96M126.54M
Total Current Liabilities % of Revenue i11.1%17.8%
Long-Term Debt iN/A467.36M
Long-Term Debt % of Revenue i0.0%65.8%
Total Shareholders Equity i198.92M318.07M
Retained Earnings i158.27M-62.10M
Retained Earnings % of Revenue i41.0%-8.7%
Property, Plant & Equipment i7.23M18.08M

Cash Flow Statement Comparison

MetricMED (2025)WW (2025)
Operating Cash Flow i8.92M-63.85M
Operating Cash Flow % of Revenue i2.3%-9.0%
Capital Expenditures i-5.61MN/A
Free Cash Flow i1.25M-46.38M
FCF Margin i0.3%-6.5%
Debt Repayment iN/AN/A
Common Stock Repurchase i-369,000N/A

Short Interest & Institutional Ownership Analysis

MetricMEDWW
Shares Short i2.06M1.49M
Short Ratio i7.144.70
Short % of Float i19.31%N/A
Shares Outstanding i10.99M10.00M
Float Shares i8.48M7.79M
% Held by Insiders i3.86%0.38%
% Held by Institutions i78.14%66.59%
% Held by Public i18.00%33.03%

Dividend Analysis & Yield Comparison: Medifast Inc. vs WW International Inc.

MetricMEDWW
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$2.74N/A
3-Year Avg Dividend Yield i1.43%N/A
3-Year Total Dividends i$8.22N/A
Ex-Dividend DateJun 26, 2023N/A